SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is experiencing a sharp sell-off driven by community reports of an FDA warning letter regarding the company's promotional and marketing language. While retail sentiment remains largely bullish and dismisses the event as a temporary compliance issue rather than a fundamental threat to the drug's efficacy or approval, many users are actively discussing potential coordinated market manipulation by short sellers attempting to trigger stop-losses.

Microsoft Corp. engages in the development and support of software, services, devices, and solutions. It operates through the following segments: Productivity and Business Processes, Intelligent Cloud, and More Personal Computing. The Productivity and Business Processes segment is composed of products and services relating to productivity, communication, and information services such as Office Commercial, Office Consumer, LinkedIn, and Dynamics business solutions. The Intelligent Cloud segment consists of public, private, and hybrid server products and cloud services for businesses and developers, as well as enterprise and partner services. The More Personal Computing segment refers to products and services including Windows operating system, Windows cloud services, Surface, HoloLens, personal computer accessories, Xbox hardware, Xbox Cloud Gaming, Microsoft News, and Microsoft Edge. The company was founded by Paul Gardner Allen and William Henry Gates, III in 1975 and is headquartered in Redmond, WA.

Microsoft Corporation

Microsoft Corp

Microsoft is facing significant selling pressure as investors grapple with escalating geopolitical tensions in the Middle East and concerns over Azure's capacity constraints versus capital expenditures. While analysts remain divided between maintaining buy ratings for the long-term AI-driven potential and cautious holds due to valuation and growth risks, the community is deeply polarized, with many debating whether the current pullback represents a generational buying opportunity or a deeper structural breakdown.

FuboTV, Inc. is a consumer-first live TV streaming company with the mission of delivering premium sports, news and entertainment programming that offers greater choice, flexibility and value. The company was founded by David Gandler, Alberto Horihuela Suarez, and Sung Ho Choi on February 20, 2009 and is headquartered in New York, NY.

fuboTV Inc - Ordinary Shares - Class A

fuboTV Inc

FuboTV is facing intense scrutiny and volatility as the company moves toward a reverse stock split, fueling deep divisions among retail investors. While some holders are speculating on a potential institutional rebound or a short squeeze, many are venting frustration over the lack of positive guidance and are actively positioning themselves to short the stock in anticipation of further downside.

AleAnna, Inc. operates as a technology-driven energy company, which engages in supplying low-carbon natural gas and renewable natural gas to Italy. The company was founded in 2007 and is headquartered in Dallas, TX.

AleAnna Inc. - Ordinary Shares - Class A

ANNA is surging due to supply-side catalysts in the global energy sector, specifically triggered by major disruptions to Middle East natural gas infrastructure that have intensified supply concerns. The community is actively discussing the stock's low float, high cost-to-borrow rates, and potential for a short squeeze, while carefully monitoring geopolitical developments that could influence price volatility.

Fundrise Innovation Fund LLC. - Common Shares of Limited Liability Company Interests

Fundrise Innovation Fund 

VCX is experiencing extreme volatility and intense community speculation following its recent NYSE debut, with traders closely monitoring its limited float and high premium to net asset value. While bulls point to the fund's early access to high-profile AI and tech firms like Anthropic and SpaceX as a long-term catalyst, bears are warning of a potential rug pull and comparing the price action to past speculative market manias.

Circle Internet Group, Inc. is a financial technology company that enables businesses of all sizes to harness the power of digital currencies and public blockchains for payments, commerce and financial applications worldwide. The company was founded by Jeremy J. Allaire and Patrick Sean Neville in August 2013 and is headquartered in New York, NY.

Circle Internet Group Inc. - Ordinary Shares - Class A

Circle

Circle (CRCL) is experiencing significant market volatility driven by institutional interest in its stablecoin infrastructure and broader regulatory optimism, even as the community debates whether the recent surge is a sustainable breakout or a speculative bubble prone to a pullback. Traders are closely monitoring the interaction between rising USDC adoption, potential legislative catalysts, and aggressive options positioning as the stock continues to attract high-conviction long and short activity.

Figma, Inc. is an AI-powered design platform that enables seamless collaboration across the entire product development lifecycle. Its products include FigJam, Figma Slides, Figma Design, Figma Draw, Dev Mode, Figma Sites, Figma Buzz and Figma Make. The company was founded by Dylan Joseph Field and Evan Darrow Wallace in 2012 and is headquartered in San Francisco, CA.

Figma Inc. - Ordinary Shares - Class A

Figma

Figma is rallying as investors digest recent earnings, insider buying activity, and strategic AI partnerships, while the community remains divided over whether the stock is primed for a major short squeeze or vulnerable to further downside amid broader software sector volatility.

Far below the surface, where light no longer reaches and noise collapses into silence, the Sperm Whale endures.  It does not rely on speed or spectacle. It survives through mass, intelligence, and absolute awareness of its surroundings.  This project is shaped by the same principle — strength formed under pressure, movement guided by understanding, and conviction built where others cannot remain.  While the surface reacts, the deep decides.

The Sperm Whale

SPERMWHALE is trending as investors debate its potential for rapid price expansion against widespread warnings that it is a high-risk pump-and-dump scheme. The community is split between those chasing the meme coin's volatile momentum and skeptics pointing to its concentrated holder structure and lack of fundamental utility.

The Walt Disney Co. engages in the business of international family entertainment and media enterprise. It owns and operates television and radio production, distribution and broadcasting stations, direct-to-consumer services, amusement parks, and hotels. It operates through the following business segments: Disney Entertainment, ESPN, and Disney Parks, Experiences, and Products. The company was founded by Walter Elias Disney on October 16, 1923 and is headquartered in Burbank, CA.

Walt Disney Co (The)

Walt Disney Co

Disney is drawing heavy attention following the official announcement that Parks Chief Josh D'Amaro will succeed Bob Iger as CEO, a move the community is actively dissecting for its potential to finally reverse the stock's long-term stagnation. While some investors are optimistic about the leadership transition and the company's aggressive buyback plans, others remain skeptical, citing persistent concerns over the firm's debt load, competitive pressures in streaming, and the stock's tendency to trade in a frustratingly flat range.

Coinbase Global, Inc. engages in the provision of a trusted platform that serves as a compliant on-ramp to the onchain economy and enables users to engage in a wide variety of activities with their crypto assets in both proprietary and third-party product experiences enabled by access to decentralized applications. It offers consumers primary financial account for the cryptoeconomy, institutions a full-service prime brokerage platform with access to deep pools of liquidity across the crypto marketplace, and developers a suite of products granting access to build onchain. The company was founded by Brian Armstrong and Fred Ernest Ehrsam in May 2012 and is headquartered in New York, NY.

Coinbase Global Inc - Ordinary Shares - Class A

Coinbase Global Inc

Coinbase is trending as the community debates its new strategic pivot into AI-agent payment infrastructure and the potential impact of the upcoming Clarity Act. Despite regulatory uncertainty regarding stablecoin yield models, sentiment is polarized between traders betting on a significant breakout fueled by institutional accumulation and those fearing a deep retracement if key support levels fail.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Voss Capital LP Boosts Stake in Actuate Therapeutics, Inc. $ACTU

Voss Capital LP raised its holdings in shares of Actuate Therapeutics, Inc. (NASDAQ:ACTU - Free Report) by 213.2% in the 3rd quarter, according to its most recent Form 13F filing with the Securities...

Actuate Therapeutics (NASDAQ:ACTU) Rating Lowered to Sell at Wall Street Zen

Wall Street Zen downgraded shares of Actuate Therapeutics from a "hold" rating to a "sell" rating in a report on Saturday...

Actuate Therapeutics (NASDAQ:ACTU) Rating Increased to Hold at Wall Street Zen

Wall Street Zen upgraded Actuate Therapeutics from a "sell" rating to a "hold" rating in a research note on Saturday...

Mettler-Toledo Q4 Earnings Top Estimates, Sales Rise Y/Y

MTD beats Q4 estimates as adjusted EPS jumps 8% Y/Y and sales rise to $1.13B, led by solid growth across Laboratory, Industrial and Food Retail.

Actuate Therapeutics, Inc. (NASDAQ:ACTU) Sees Significant Growth in Short Interest

Actuate Therapeutics, Inc. (NASDAQ:ACTU - Get Free Report) saw a significant increase in short interest in the month of December. As of December 31st, there was short interest totaling 529,786...

Actuate Therapeutics (NASDAQ:ACTU) Downgraded by Wall Street Zen to "Sell"

Wall Street Zen downgraded Actuate Therapeutics from a "hold" rating to a "sell" rating in a research note on Saturday...

Actuate Therapeutics (NASDAQ:ACTU) Trading 2.7% Higher - Here's What Happened

Actuate Therapeutics (NASDAQ:ACTU) Trading 2.7% Higher - Time to Buy...

Actuate Therapeutics, Inc. (ACTU) Upgraded to Buy: What Does It Mean for the Stock?

Actuate Therapeutics, Inc. (ACTU) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Voss Capital LP Purchases 143,759 Shares of Actuate Therapeutics, Inc. $ACTU

Voss Capital LP grew its position in Actuate Therapeutics, Inc. (NASDAQ:ACTU - Free Report) by 101.0% in the 2nd quarter, according to its most recent filing with the SEC. The firm owned 286,140...

How Much Upside is Left in Actuate Therapeutics, Inc. (ACTU)? Wall Street Analysts Think 214.06%

The average of price targets set by Wall Street analysts indicates a potential upside of 214.1% in Actuate Therapeutics, Inc. (ACTU). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

Actuate Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in developing therapeutics which target cancers and neurodegenerative diseases. It offers treatment for cancer and inflammatory diseases. It focuses on developing elraglusib. The company was founded by Andrew P. Mazar on January 16, 2015 and is headquartered in Fort Worth, TX.

ACTU
Actuate Therapeutics Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest ACTU News

ACTUActuate Therapeutics Inc.